Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 16. Chang E, Johnson P N, Medina M, Dennis V C, Neely S, Miller J L. Sculpting a teaching and learning curriculum to better meet the career needs of postgraduate year 1 and 2 pharmacy residents. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2023; 80 : 765-771
17. Bradford C V, Miller J L, Ranallo C D, Neely S, Johnson P N. Vasopressin-Induced Hyponatremia in Infants Following Cardiovascular Surgery. The Annals of pharmacotherapy. 2023; 57 : 259-266
18. Johnson P N. Pain and Sedation. Pediatric Pharmacy Association. 2023 : 221-36
19. Harrison K, Fox A, Miller J L, Neely S, Dennis V C, Johnson P N. A survey of post-graduate pharmacy residency graduates involved in a team-based research programme: Involvement and confidence in research and scholarship activities. Pharmacy Education. 2023; 23 : 430-439
20. Chang E, Ballard K E, Johnson P N, Nandyal R, Miller J L. Azithromycin for Eradication of Ureaplasma and Prevention of Bronchopulmonary Dysplasia in Preterm Neonates in the Neonatal Intensive Care Unit. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2023; 28 : 10-19
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 31. Pediatric Pharmacy Advocacy Group. Board of Directors Nominee. Date: 2011.
32. University of Oklahoma College of Medicine, Department of Pediatrics. Department of Pediatrics Teaching Award. Date: 2009.
33. Pediatric Pharmacy Advocacy Group. Spirit of PPAG Award. Date: 2008.
34. University of Kentucky Chandler Medical Center. Pharmacy Resident Extra Mile Award. Date: 2006.
35. University of Kentucky College of Pharmacy. Rho Chi Research Symposium--1st Place Award Winner. Date: 2006.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results